檢索結果 - Marjolein Sluijter
- Showing 1 - 16 results of 16
-
1
-
2
-
3
-
4
-
5
-
6
Cancer vaccines compensate for the insufficient induction of protective tumor-specific immunity of CD3 bispecific antibody therapy 由 Jim Middelburg, Gaby Schaap, Marjolein Sluijter, Katy A. Lloyd, Vitalijs Ovcinnikovs, Janine Schuurman, Sjoerd H. van der Burg, Kristel Kemper, Thorbald van Hall
出版 2025Artigo -
7
CD3-Bispecific Antibody Therapy Turns Solid Tumors into Inflammatory Sites but Does Not Install Protective Memory 由 Hreinn Benonisson, Işıl Altıntaş, Marjolein Sluijter, Sandra Verploegen, Aran F. Labrijn, Danita H. Schuurhuis, Mischa Houtkamp, J. Sjef Verbeek, Janine Schuurman, Thorbald van Hall
出版 2018Artigo -
8
-
9
Therapeutic Peptide Vaccine-Induced CD8 T Cells Strongly Modulate Intratumoral Macrophages Required for Tumor Regression 由 Tetje C. van der Sluis, Marjolein Sluijter, Suzanne van Duikeren, Brian L. West, Cornelis J.M. Melief, Ramon Arens, Sjoerd H. van der Burg, Thorbald van Hall
出版 2015Artigo -
10
The nonpolymorphic MHC Qa-1b mediates CD8+ T cell surveillance of antigen-processing defects 由 Cláudia C. Oliveira, Peter A. van Veelen, Bianca Querido, Arnoud de Ru, Marjolein Sluijter, Sandra Laban, Jan W. Drijfhout, Sjoerd H. van der Burg, Rienk Offringa, Thorbald van Hall
出版 2010Artigo -
11
-
12
<scp>NKG2A</scp> is a late immune checkpoint on <scp>CD8</scp> T cells and marks repeated stimulation and cell division 由 Linda Borst, Marjolein Sluijter, Gregor Sturm, Pornpimol Charoentong, Saskia J. Santegoets, Mandy van Gulijk, Marit J van Elsas, Christianne Groeneveldt, Nadine van Montfoort, Francesca Finotello, Zlatko Trajanoski, Szymon M. Kiełbasa, Sjoerd H. van der Burg, Thorbald van Hall
出版 2021Artigo -
13
Immunotherapy-activated T cells recruit and skew late-stage activated M1-like macrophages that are critical for therapeutic efficacy 由 Marit J van Elsas, Jim Middelburg, Camilla Labrie, Jessica Roelands, Gaby Schaap, Marjolein Sluijter, Ruxandra Tonea, Vitalijs Ovcinnikovs, Katy A. Lloyd, Janine Schuurman, Samantha J. Riesenfeld, Thomas F. Gajewski, Noel F.C.C. de Miranda, Thorbald van Hall, Sjoerd H. van der Burg
出版 2024Artigo -
14
NKG2A Blockade Potentiates CD8 T Cell Immunity Induced by Cancer Vaccines 由 Nadine van Montfoort, Linda Borst, Michael Korrer, Marjolein Sluijter, Koen A. Marijt, Saskia J. Santegoets, Vanessa J. van Ham, Ilina Ehsan, Pornpimol Charoentong, Pascale André, Nicolai Wagtmann, Marij J.P. Welters, Young J. Kim, Sytse J. Piersma, Sjoerd H. van der Burg, Thorbald van Hall
出版 2018Artigo -
15
Targeting pancreatic cancer by TAK-981: a SUMOylation inhibitor that activates the immune system and blocks cancer cell cycle progression in a preclinical model 由 Sumit Kumar, Mark J.A. Schoonderwoerd, Jessie S. Kroonen, Ilona J. de Graaf, Marjolein Sluijter, Dina Ruano, Román González‐Prieto, Matty Verlaan–de Vries, Jasper Rip, Ramon Arens, Noel F.C.C. de Miranda, Lukas J.A.C. Hawinkels, Thorbald van Hall, Alfred C.O. Vertegaal
出版 2022Artigo -
16
T-cell stimulating vaccines empower CD3 bispecific antibody therapy in solid tumors 由 Jim Middelburg, Marjolein Sluijter, Gaby Schaap, Büşra Göynük, Katy A. Lloyd, Vitalijs Ovcinnikovs, Gijs G. Zom, Renoud J. Marijnissen, Christianne Groeneveldt, Lisa Griffioen, Gerwin W. Sandker, Sandra Heskamp, Sjoerd H. van der Burg, Tsolère Arakelian, Ferry Ossendorp, Ramon Arens, Janine Schuurman, Kristel Kemper, Thorbald van Hall
出版 2024Artigo
相關主題
Immunology
Immune system
CD8
Biology
Cancer research
In vitro
Antigen
Biochemistry
Cytotoxic T cell
Immunotherapy
T cell
Medicine
Cell biology
MHC class I
Major histocompatibility complex
Cancer
Genetics
Internal medicine
Antibody
Chemistry
Epitope
Antigen processing
Antigen-presenting cell
Bispecific antibody
Cancer immunotherapy
Macrophage
Monoclonal antibody
Receptor
Antibody therapy
Antigen presentation